Sarepta Therapeutics Inc
NASDAQ:SRPT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Sarepta Therapeutics Inc
Wall Street
Price Targets
SRPT Price Targets Summary
Sarepta Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SRPT
is 171.26 USD
with a low forecast of 129.28 USD and a high forecast of 235.2 USD.
SRPT Last Price Targets
Sarepta Therapeutics Inc
The latest public price target was made on Jun 13, 2024 by
Brian Skorney
from
Robert W. Baird
,
who expects
SRPT
stock to
rise by 38%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SRPT's stock price target?
Price Target
171.26
USD
According to Wall Street analysts, the average 1-year price target for
SRPT
is 171.26 USD
with a low forecast of 129.28 USD and a high forecast of 235.2 USD.
What is Sarepta Therapeutics Inc's Revenue forecast?
Projected CAGR
41%
For the last 8 years the
compound annual growth rate for
Sarepta Therapeutics Inc's revenue is
136%.
The projected
CAGR
for the next 3 years is
41%.
You don't have any saved screeners yet
